The federal Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) advises, assists, and makes recommendations to the Secretary of HHS, through the Assistant Secretary for Health, on issues related to the safety of blood, blood products, organs, and tissues. For solid organs and blood stem cells, the Committee’s work is limited to policy issues related to donor-derived infectious disease complications of transplantation.
The Committee consists of 23 voting members who represent a diverse group of health professionals, patient advocates, and scientists; representatives from blood, tissue and organ professional organizations; and relevant manufacturing and healthcare organizations. In addition, there are 8 non-voting ex-officio members from HHS agencies and the Department of Defense. For more information on membership requirements, please refer to the ACBTSA charter. For information on current Committee members, please refer to the roster.